NYSE:DLB

Dolby Laboratories Stock News

Technology > Information Technology Services

Buy DLB

*Your capital is at risk

$54.89

-0.720 (-1.29%)

At Close: Jun 03, 2026

Dolby's Q4 Earnings Surpass Estimates, Revenues Increase Y/Y

10:45am, Wednesday, 20'th Nov 2024

DLB's fiscal Q4 2024 performance gains from steady growth in the Licensing business amid softness in the Products and services segments.

Dolby Laboratories (DLB) Reports Q4 Earnings: What Key Metrics Have to Say

08:01pm, Tuesday, 19'th Nov 2024

While the top- and bottom-line numbers for Dolby Laboratories (DLB) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key met

Dolby Laboratories (DLB) Surpasses Q4 Earnings Estimates

06:35pm, Tuesday, 19'th Nov 2024

Dolby Laboratories (DLB) came out with quarterly earnings of $0.81 per share, beating the Zacks Consensus Estimate of $0.68 per share. This compares to earnings of $0.65 per share a year ago.

Dolby Laboratories, Inc. (DLB) Q4 2024 Earnings Call Transcript

06:18pm, Tuesday, 19'th Nov 2024

Dolby Laboratories, Inc. (NYSE:DLB ) Q4 2024 Earnings Conference Call November 19, 2024 5:00 PM ET Company Participants Peter Goldmacher - VP, IR Kevin Yeaman - CEO Robert Park - CFO Conference Call P

Dolby Laboratories Reports Fourth Quarter and Fiscal Year 2024 Financial Results

04:15pm, Tuesday, 19'th Nov 2024

SAN FRANCISCO , Nov. 19, 2024 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the fourth quarter and fiscal year 2024. "We are pleased with the

Dolby to Post Q4 Earnings: Here's What Investors Should Know

09:56am, Monday, 18'th Nov 2024

DLB's Q4 performance is likely to have been affected by soft device shipments and sluggish box office performance amid momentum across Dolby Atmos and Dolby Vision.

Curious about Dolby Laboratories (DLB) Q4 Performance? Explore Wall Street Estimates for Key Metrics

10:15am, Thursday, 14'th Nov 2024

Besides Wall Street's top -and-bottom-line estimates for Dolby Laboratories (DLB), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared dur

Dolby Laboratories (DLB) Reports Next Week: Wall Street Expects Earnings Growth

11:00am, Tuesday, 12'th Nov 2024

Dolby Laboratories (DLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Cognition Therapeutics Releases New Episode of “Conversations” Podcast: Executing Clinical Research in Dementia with Lewy Bodies (DLB)

07:30am, Tuesday, 22'nd Oct 2024

PURCHASE, N.Y., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenera

Dolby Laboratories President and CEO Kevin Yeaman to Host Fireside Chat at the Goldman Sachs Communacopia and Technology Conference

04:15pm, Thursday, 05'th Sep 2024

SAN FRANCISCO , Sept. 5, 2024 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced that Kevin Yeaman, President and CEO, will host a fireside chat at the Goldman Sachs Communacopia and

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by